TY  - GEN
AU  - Soler-Agesta, R
AU  - Moreno-Loshuertos, R
AU  - Yim, C Y
AU  - Congenie, M T
AU  - Ames, T D
AU  - Johnson, H L
AU  - Stossi, F
AU  - Mancini, M G
AU  - Mancini, M A
AU  - Ripollés-Yuba, C
AU  - Marco-Brualla, J
AU  - Junquera, C
AU  - Martínez-De-Mena, R
AU  - Enríquez, J A
AU  - Price, M R
AU  - Jimeno, J
AU  - Anel, A
PY  - 2024
UR  - https://hdl.handle.net/20.500.12105/25852
AB  - PT-112 is a novel immunogenic cell death (ICD)-inducing small molecule currently under Phase 2 clinical development, including in metastatic castration-resistant prostate cancer (mCRPC), an immunologically cold and heterogeneous disease state in need...
LA  - eng
PB  - BioMed Central (BMC)
KW  - Autophagy
KW  - Immunogenic cell death
KW  - Mitochondrial stress
KW  - PT-112
KW  - Prostate cancer
TI  - Cancer cell-selective induction of mitochondrial stress and immunogenic cell death by PT-112 in human prostate cell lines.
TY  - research article
ER  -